Log In
BCIQ
Print this Print this
 

Anginera

  Manage Alerts
Collapse Summary General Information
Company Theregen Corp.
DescriptionEpicardial patch
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCoronary artery disease (CAD)
Indication DetailsTreat diffuse small vessel coronary artery disease (CAD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today